Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast. The company may soon find itself in a position where ...Read Full Story »

